GeneDx (WGSWW) Stock Price, News & Analysis

Company Overview

GeneDx is a genetic testing company headquartered in Gaithersburg, Maryland. Established in 2000 as a spin-off from the National Institutes of Health, the company focuses on using advanced genomic technologies to diagnose rare inherited disorders. Its CLIA- and CAP-accredited laboratory offers a broad range of tests including whole-exome sequencing, targeted gene panels, microarray analysis and pharmacogenomic profiling.

GeneDx’s testing services cover multiple clinical specialties such as neurology, cardiology, endocrinology and oncology. The company collaborates with healthcare providers, academic institutions and biopharmaceutical companies to support patient care, research and drug development. In addition to diagnostic offerings, GeneDx provides genetic counseling support and digital reporting tools designed to enhance clinical decision-making and patient outcomes.

In March 2018, GeneDx became part of BioReference Laboratories, itself a subsidiary of OPKO Health, expanding its reach within a global diagnostics network. The company processes thousands of samples from patients in North America, Europe, Asia and Latin America. GeneDx maintains a team of board-certified geneticists, laboratory scientists and genetic counselors, aiming to advance genomic medicine through continuous innovation and robust data interpretation methodologies.

Key Stats

• Today's Range: $0.11 to $0.13
• 50-Day Range: $0.03 to $0.13
• 52-Week Range: $0.02 to $0.34
• Volume: 27,640 shs
• Average Volume: 66,988 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

WGSWW Stock Analysis - Frequently Asked Questions

How have WGSWW shares performed this year?

GeneDx's stock was trading at $0.16 on January 1st, 2025. Since then, WGSWW shares have decreased by 29.9% and is now trading at $0.1122.

How do I buy shares of GeneDx?

Shares of WGSWW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: NASDAQ:WGSWW
• CIK: 1818331
• Web: www.genedx.com
• Phone: 800-298-6470
• Fax: N/A
• Employees: 1,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $362.32 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A